| abstract |
Compounds according to the invention are compounds of formula (I), or racemic compounds, optical isomers or diastereomers thereof, or mixtures thereof, or salts thereof: Formula (I): RA-Gly-His-B-R ' In formula (I): A and B are independent of each other and are L-lysine residues or D-lysine residues comprising a L-lysine residue, a D-lysine residue, or a side chain NH 2 group modification, wherein the modification is (i ) Hydrogen substitution, (ii) acetylation, (iii) benzoylation, or (iv) palmitoylation; Gly is a glycine residue; His is an L histidine residue or a D-histidine residue; R is an amino terminal modification of CH 3- (CH 2 ) n -CO- and n is 2, 3, 4, 5, 6, 7 or 8; R 'is a formula (II) group: [Formula (II)] N (Z) (Z ') In the formula (II): Z and Z 'are hydrogen, methyl group, ethyl group, phenyl group, hexyl group, decyl group or hexadecyl. |